QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)

Pfizer - PFE SEC Filings & 10K Form

$48.29
-1.66 (-3.32%)
(As of 08/11/2022 12:00 AM ET)
Add
Compare
Today's Range
$47.81
$49.13
50-Day Range
$46.53
$53.96
52-Week Range
$40.94
$61.71
Volume
43.82 million shs
Average Volume
27.21 million shs
Market Capitalization
$270.95 billion
P/E Ratio
9.45
Dividend Yield
3.20%
Price Target
$57.50

Recent Pfizer SEC Filings

DateFilerForm TypeView
08/10/2022
3:26 PM
Pfizer (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2022
2:42 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2022
2:42 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2022
2:41 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2022
11:40 AM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2022
11:39 AM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2022
11:39 AM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2022
5:17 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2022
5:17 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2022
5:17 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2022
3:53 PM
Pfizer (Issuer)
SMITH JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2022
3:53 PM
Pfizer (Issuer)
Quincey James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2022
3:53 PM
NARAYEN SHANTANU (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2022
3:53 PM
Echevarria Joseph (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2022
4:07 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2022
4:07 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2022
4:07 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2022
4:09 PM
Pfizer (Filed by)
Valneva SE (Subject)
Form SC 13G
06/28/2022
3:19 PM
Akero Therapeutics, Inc. (Subject)
Pfizer (Filed by)
Form SC 13G
06/16/2022
1:07 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
1:07 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
1:06 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2022
1:13 PM
Pfizer (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/09/2022
1:09 PM
Pfizer (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/08/2022
3:43 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2022
4:51 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2022
4:50 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2022
4:50 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2022
4:50 PM
Denton David M (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2022
6:48 AM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2022
8:23 PM
Pfizer (Issuer)
SAHNI PAYAL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2022
8:22 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2022
8:22 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2022
4:38 PM
Carapezzi William R JR (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2022
4:19 PM
LANKLER DOUGLAS M (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2022
3:34 PM
Dolsten Mikael (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2022
3:34 PM
Pfizer (Issuer)
SUSMAN SALLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2022
3:19 PM
Pfizer (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2022
6:08 AM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2022
12:19 PM
Denton David M (Reporting)
Pfizer (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/03/2022
7:08 AM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2022
3:20 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2022
3:19 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2022
3:19 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
3:22 PM
Pfizer (Issuer)
Quincey James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
3:21 PM
NORA JOHNSON SUZANNE M (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
3:21 PM
NARAYEN SHANTANU (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
3:20 PM
LITTMAN DAN R. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
3:15 PM
Echevarria Joseph (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
3:15 PM
Desmond-Hellmann Susan (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2022
4:30 PM
Pfizer (Filer)
Form DEFA14A
04/20/2022
3:41 PM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2022
12:49 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2022
12:49 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2022
12:49 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2022
2:00 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2022
2:00 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2022
2:00 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2022
1:38 PM
Pfizer (Subject)
Tara Health Foundation (Filed by)
Form PX14A6G
04/12/2022
3:24 PM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2021
3:25 PM
ARVINAS, INC. (Subject)
Pfizer (Filed by)
Form SC 13G
09/16/2021
5:10 PM
Pfizer (Issuer)
YOUNG JOHN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2021
5:10 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2021
5:09 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2021
5:09 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
3:03 PM
Pfizer (Issuer)
YOUNG JOHN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
3:03 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
3:03 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
3:03 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2021
3:06 PM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2021
7:13 PM
Pfizer (Issuer)
YOUNG JOHN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2021
7:13 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2021
7:12 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2021
7:12 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2021
7:52 AM
Pfizer (Filer)
Form 424B3
08/12/2021
3:01 PM
Pfizer (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2021
6:03 PM
Pfizer (Issuer)
YOUNG JOHN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
6:03 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
6:03 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
6:02 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2021
7:04 AM
Pfizer (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2021
2:49 PM
Pfizer (Issuer)
YOUNG JOHN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2021
2:49 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2021
2:49 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2021
2:49 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2021
3:16 PM
Cerevel Therapeutics Holdings, Inc. (Subject)
Pfizer (Filed by)
Form SC 13D/A
07/01/2021
3:10 PM
Pfizer (Issuer)
YOUNG JOHN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2021
3:10 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2021
3:09 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2021
3:08 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
1:01 PM
Pfizer (Issuer)
YOUNG JOHN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
1:01 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
1:01 PM
DAMICO JENNIFER B. (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
1:01 PM
BOURLA ALBERT (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
1:47 PM
Pfizer (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/07/2021
1:45 PM
Pfizer (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/07/2021
1:44 PM
Pfizer (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
05/17/2021
3:44 PM
JOHNSON RADY A (Reporting)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2021
3:44 PM
Pfizer (Issuer)
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2021
3:43 PM
Pfizer (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NYSE:PFE) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.